Can Fezonatant be purchased legally in China? Channel and Compliance Analysis

Fezolinetant (Fezolinetant) is a new type of oral drug mainly used to treat symptoms such as menopausal hot flashes. It is a neurokinin receptor antagonist. At present, Fezonatan has not been officially launched in China, so domestic patients cannot purchase the drug through formal channels. This means that patients in China are temporarily unable to rely on hospitals or pharmacies to obtain fezonatant for treatment.

Since Fezonatant has not been approved by the domestic drug regulatory authorities, its sales and circulation lack legal protection. If patients purchase it through informal channels without permission, there will be drug safety and legal risks. Therefore, it is recommended that patients pay attention to the latest drug registration trends from official channels and avoid blindly purchasing drugs from unknown sources to ensure drug safety.

In overseas markets, fezonatant has been launched in some countries and regions. For example, the generic version produced by Lucius Pharmaceutical Factory in Laos is already on the market. The specification is 45mg*30 tablets, and the price is about 900 yuan. Because the price of this generic drug is relatively affordable, it provides an economic choice for some patients, but patients should confirm the formality of the source of the drug and ensure the quality of the drug.

Generally speaking, fezonatant has not been legally marketed in China. If patients need medication, they can consider obtaining it through regular overseas channels, but they must choose carefully and follow the doctor's instructions. At the same time, with the advancement of the drug approval process, Fezonatan is expected to enter the domestic market in the future, bringing new treatment options to more patients.

Reference materials:https://www.drugs.com